Category: <span>moffitt cancer center</span>

Many Mesothelioma Centers Top List of Best Cancer Hospitals

The University of Texas MD Anderson Cancer Center retained its standing as the top cancer care hospital in the nation for the second consecutive year, according to U.S. News & World Report. The publication’s 2016-17 Best Hospitals for Cancer graded cancer centers from 0-100 on a variety of categories such as reputation with specialists, volume…

The post Many Mesothelioma Centers Top List of Best Cancer Hospitals appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Mesothelioma Treatment Guidelines May Extend Survival

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Mesothelioma Treatment Guidelines May Extend Survival

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Mesothelioma Treatment Guidelines May Extend Survival

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.